Ottawa Heart Institute Research Corporation

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

A Pharmacodynamic Study of a Personalized Strategy for P2Y12 Inhibition Versus Ticagrelor in Reducing Ischemic and Bleeding Risk

Phase 2

Completed

Conditions: Acute Coronary Syndrome
Percutaneous Coronary Intervention

Interventions: Drug: Ticagrelor, Prasugrel, Clopidogrel

First Posted Date: 2014-01-23

Last Posted Date: 2018-10-05

Lead Sponsor: Ottawa Heart Institute Research Corporation

Target Recruit Count: 120

Registration Number: NCT02044146

Locations: 🇨🇦
University of Ottawa Heart Institute, Ottawa, Ontario, Canada
🇨🇦
Montreal Heart Institute, Montreal, Quebec, Canada

CO2 as a Stress Agent for Perfusion Imaging

Not Applicable

Terminated

Conditions: Coronary Artery Disease

Interventions: Device: Delivery of precise levels of carbon dioxide with the RA-MR™ Virtual Sequential Gas Delivery System.
Device: Delivery of rubidium radioisotope (Rb-82) using the automated pump/elution system

First Posted Date: 2014-01-23

Last Posted Date: 2021-04-02

Lead Sponsor: Ottawa Heart Institute Research Corporation

Target Recruit Count: 20

Registration Number: NCT02043535

Locations: 🇨🇦
University Of Ottawa Heart Institute, Ottawa, Ontario, Canada

Prognostic Value of Stress SPECT Myocardial Perfusion Imaging With Half Dose 99mTc-Tetrofosmin

Completed

Conditions: Cardiovascular Disease

First Posted Date: 2013-12-24

Last Posted Date: 2017-04-13

Lead Sponsor: Ottawa Heart Institute Research Corporation

Target Recruit Count: 4000

Registration Number: NCT02019212

Locations: 🇨🇦
University of Ottawa Heart Insitute, Ottawa, Ontario, Canada

Mild Versus Moderate Therapeutic Hypothermia in Out-of-hospital Cardiac Arrest Patients

Not Applicable

Completed

Conditions: Cardiac Arrest

Interventions: Other: Therapeutic Hypothermia

First Posted Date: 2013-12-13

Last Posted Date: 2024-12-06

Lead Sponsor: Ottawa Heart Institute Research Corporation

Target Recruit Count: 389

Registration Number: NCT02011568

Locations: 🇨🇦
University of Ottawa Heart Institute, Ottawa, Ontario, Canada

Resynchronization/Defibrillation for Ambulatory Heart Failure Trial in Patients With Permanent Atrial Fibrillation

Not Applicable

Active, not recruiting

Conditions: Congestive Heart Failure
Heart Disease
Atrial Fibrillation

Interventions: Device: Optimal Medical therapy plus CRT/ICD
Device: Optimal Medical therapy plus ICD

First Posted Date: 2013-11-25

Last Posted Date: 2024-05-10

Lead Sponsor: Ottawa Heart Institute Research Corporation

Target Recruit Count: 200

Registration Number: NCT01994252

Locations: 🇨🇦
Libin Cardiovascular Institute of Alberta, Calgary, Alberta, Canada
🇨🇦
St. Boniface General Hospital, Winnipeg, Manitoba, Canada
🇨🇦
Kingston General Hospital, Kingston, Ontario, Canada

and more 12 locations

The Role of Vitamin D in the Pathophysiology of Chronic Failure

Phase 4

Completed

Conditions: Chronic Heart Failure
Vitamin D Deficiency

Interventions: Drug: Vitamin D

First Posted Date: 2013-11-25

Last Posted Date: 2016-03-03

Lead Sponsor: Ottawa Heart Institute Research Corporation

Target Recruit Count: 91

Registration Number: NCT01993537

Locations: 🇨🇦
The University of Ottawa Heart Institute, Ottawa, Ontario, Canada

Evaluation of the Ottawa Model for Smoking Cessation in Diabetes Education Programs

Not Applicable

Completed

Conditions: Diabetic Type II Mellitus
Pre-diabetic

Interventions: Behavioral: Ottawa Model for Smoking Cessation

First Posted Date: 2013-11-08

Last Posted Date: 2022-04-20

Lead Sponsor: Ottawa Heart Institute Research Corporation

Target Recruit Count: 313

Registration Number: NCT01980017

Locations: 🇨🇦
University of Ottawa Heart Institute, Ottawa, Ontario, Canada

Ticagrelor vs Clopidogrel Effect on MFR in CAD Population

Phase 2

Completed

Conditions: Coronary Artery Disease

Interventions: Drug: Ticagrelor
Drug: Clopidogrel

First Posted Date: 2013-07-10

Last Posted Date: 2017-04-24

Lead Sponsor: Ottawa Heart Institute Research Corporation

Target Recruit Count: 36

Registration Number: NCT01894789

Locations: 🇨🇦
University of Ottawa Heart Institute, Ottawa, Ontario, Canada

Strategy of Continued Versus Interrupted Novel Oral Anti-coagulant at Time of Device Surgery in Patients With Moderate to High Risk of Arterial Thromboembolic Events

Phase 3

Completed

Conditions: Hematoma

Interventions: Drug: Dabigatran
Drug: Rivaroxaban
Drug: Apixaban

First Posted Date: 2012-08-29

Last Posted Date: 2019-10-07

Lead Sponsor: Ottawa Heart Institute Research Corporation

Target Recruit Count: 663

Registration Number: NCT01675076

Locations: 🇨🇦
Victoria Cardiac Arrhythmia Trials Inc., Victoria, British Columbia, Canada
🇨🇦
University of Alberta-ECAT Group, Edmonton, Alberta, Canada
🇨🇦
Hamilton Health Sciences General Campus, Hamilton, Ontario, Canada

and more 12 locations

The Efficacy and Economics of Exercise Maintenance Post-Cardiac Rehabilitation

Not Applicable

Completed

Conditions: Coronary Artery Disease

Interventions: Behavioral: Exercise Facilitator Intervention

First Posted Date: 2012-08-07

Last Posted Date: 2022-03-10

Lead Sponsor: Ottawa Heart Institute Research Corporation

Target Recruit Count: 451

Registration Number: NCT01658683

Locations: 🇨🇦
University of Ottawa Heart Institute, Ottawa, Ontario, Canada
🇨🇦
York University and University Health Network, Toronto, Ontario, Canada

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy